Biggest News Aggregation in the World
📰 Ming Yan News

Page 4 - Ming Yan News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ming Yan. Real-time updates on events, politics, business and more.

Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Update

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 11,210,000 shares, an increase of 66.1% from the April 30th total of 6,750,000 shares. Based on an average daily volume of 1,350,000 shares, the […]
New York United States Ming Yan Piper Sandler Patrik Jeanmonod Cytek Biosciences

Cytek Biosciences (NASDAQ:CTKB) Shares Up 7.3%

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) shares shot up 7.3% during mid-day trading on Monday . The company traded as high as $7.54 and last traded at $7.54. 61,179 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 1,113,310 shares. The stock had previously closed at $7.03. […]
Piper Sandler Patrik Jeanmonod Ming Yan Cytek Biosciences Royal Bank Ensign Peak Advisors Inc

Insider Selling: Cytek Biosciences, Inc. (NASDAQ:CTKB) CTO Sells 20,000 Shares of Stock

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CTO Ming Yan sold 20,000 shares of the stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $7.19, for a total value of $143,800.00. Following the sale, the chief technology officer now directly owns 7,870,258 shares of the […]
United States Cytek Biosciences Ming Yan Piper Sandler Mirae Asset Global Investments Co Goldman Sachs Group

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cytek Biosciences (NASDAQ:CTKB) Shares Down 3.7%

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) shares dropped 3.7% during mid-day trading on Monday . The stock traded as low as $11.44 and last traded at $11.48. Approximately 23,005 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 999,321 shares. The stock had previously closed at $11.92. […]
Piper Sandler Cytek Biosciences Ming Yan Patrik Jeanmonod Goldman Sachs Group Perceptive Advisors

Cytek Biosciences, Inc. (NASDAQ:CTKB) Sees Large Increase in Short Interest

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 6,510,000 shares, an increase of 15.2% from the March 31st total of 5,650,000 shares. Approximately 6.0% of the shares of the company are short […]
United States Piper Sandler Cytek Biosciences Patrik Jeanmonod Ming Yan Life Insurance Co
Source: wkrb13.com

Cytek Biosciences (NASDAQ:CTKB) Shares Down 5.1%

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating)’s share price fell 5.1% during trading on Monday . The company traded as low as $8.69 and last traded at $8.72. 463,365 shares traded hands during mid-day trading, a decline of 34% from the average session volume of 700,289 shares. The stock had previously closed at $9.19. Analysts […]
Piper Sandler Cytek Biosciences Patrik Jeanmonod Ming Yan Blackrock Inc Vanguard Group Inc

Insider Selling: Cytek Biosciences, Inc. (NASDAQ:CTKB) CTO Sells 20,000 Shares of Stock

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CTO Ming Yan sold 20,000 shares of the stock in a transaction on Monday, March 20th. The shares were sold at an average price of $9.29, for a total value of $185,800.00. Following the completion of the sale, the chief technology officer now owns 7,906,053 shares of the […]
Cytek Biosciences Piper Sandler Ming Yan Lazard Asset Management Goldman Sachs Group Morgan Stanley

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science